As mayor’s administration tiptoes around overdose prevention centers, Councilman Dorsey says they’re needed now
5 min read
Forever standing in solidarity with those who use drugs in Baltimore and beyond.
With a focus on harm reduction, Baltimore’s strategic plan looks to cut fatal overdoses 40% by 2040
Baltimore's draft strategic plan lists myriad goals, but it also contains some ambiguity, leaving the door open for programs such as overdose prevention centers.
Baltimore's landmark opioid case faces another delay, but public hearings are finally coming
A judge has granted the city an extension in the historic case, giving it more time to decide whether to accept a significantly lower award from a jury verdict last year or opt for a new trial. However, public hearings are on the horizon.
BPD data makes it hard to argue that Baltimore's drug war isn't alive and well
Earlier this week, the Baltimore Beat published my deep dive on the War on Drugs in Baltimore. Nearly everyone arrested and charged with drug "crimes" is Black.
In Baltimore's drug war, 'public safety' comes before public health. Nearly all of those impacted are Black
City officials have found themselves unable — or unwilling — to let go of punitive drug enforcement and the millions of dollars it takes to bankroll the cops who carry it out.
Baltimore's landmark lawsuit is flawed — and so is the public's view on opioids
Earlier this week, Baltimore City Circuit Court Judge P. Lawrence Fletcher-Hill rejected the city's $5.2 billion ask for abatement and reversed a $266 million jury verdict from last year. It shed light on the lawsuit's flaws, but there's more to the story.
Judge Rejects Baltimore's $5.2 Billion Lawsuit Request to Address OD Crisis
Baltimore City Circuit Court Judge Lawrence P. Fletcher-Hill said the city failed to prove that it needed McKesson and Cencora to pay $5.2 billion to cover the costs of redressing the damages they allegedly caused.
